SIM
EIGR

Sonora Investment Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Sonora Investment Management’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$5K Hold
27
– – ﹤0.01% 891
2021
Q2 		$7K Hold
27
– – ﹤0.01% 775
2021
Q1 		$7K Hold
27
– – ﹤0.01% 1428
2020
Q4 		$10K Hold
27
– – ﹤0.01% 1239
2020
Q3 		$7K Hold
27
– – ﹤0.01% 1360
2020
Q2 		$8K Buy
+27
New +$7.96K ﹤0.01% 1202

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
PAWC
P.A.W. Capital Greenwich, Connecticut $131M AUM 35.16% 1-Year Est. Return

Sonora Investment Management's EIGR Position: Q3 2021 in Review

Sonora Investment Management held its Eiger BioPharmaceuticals, Inc. (EIGR) position steady in Q3 2021 at 27 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #891.

Sonora Investment Management first reported a position in EIGR in Q2 2020 and has held it in 6 quarters since. The position peaked at $10K in Q4 2020. 92 funds tracked by Wall St. Rank hold EIGR as of Q3 2021.

  • Sonora Investment Management held 27 shares of Eiger BioPharmaceuticals, Inc. worth $5K as of Q3 2021.
  • Sonora Investment Management left its Eiger BioPharmaceuticals, Inc. share count unchanged in Q3 2021.
  • Eiger BioPharmaceuticals, Inc. made up ﹤0.01% of Sonora Investment Management's portfolio in Q3 2021, its #891 holding.
  • Sonora Investment Management first reported a position in Eiger BioPharmaceuticals, Inc. in Q2 2020 and has held it in 6 quarters since.
  • Sonora Investment Management's Eiger BioPharmaceuticals, Inc. position peaked at $10K in Q4 2020.
  • 92 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.